Andrew Don-Wauchope
Andrew Don-Wauchope
Professor, Pathology and Molecular Medicine, McMaster University
Verified email at - Homepage
Cited by
Cited by
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.
Bornstein SR , Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD ...
J Clin Endocrinol Metab. 101 (2), 364-89, 2016
Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ...
Canadian Journal of Cardiology 34 (5), 506-525, 2018
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
S Chiu, JL Sievenpiper, RJ De Souza, AI Cozma, A Mirrahimi, AJ Carleton, ...
European journal of clinical nutrition 68 (4), 416-423, 2014
Bone turnover markers in the management of postmenopausal osteoporosis
JP Brown, C Albert, BA Nassar, JD Adachi, D Cole, KS Davison, ...
Clinical biochemistry 42 (10-11), 929-942, 2009
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review
PL Santaguida, AC Don-Wauchope, M Oremus, R McKelvie, U Ali, SA Hill, ...
Heart failure reviews 19 (4), 453-470, 2014
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence
SA Hill, RA Booth, PL Santaguida, A Don-Wauchope, JA Brown, ...
Heart failure reviews 19 (4), 421-438, 2014
The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review
Y Huang, A Craig Don-Wauchope
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2011
BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure
M Oremus, A Don-Wauchope, R McKelvie, PL Santaguida, S Hill, ...
Heart failure reviews 19 (4), 471-505, 2014
Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ...
Canadian Journal of Cardiology 36 (5), 596-624, 2020
Clinical and radiological features of patients with macroprolactinaemia
MWJ Strachan, WL Teoh, AC Don‐Wauchope, J Seth, M Stoddart, ...
Clinical Endocrinology 59 (3), 339-346, 2003
Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM)–does it leverage any advantage in clinical decision making?
C Florkowski, A Don-Wauchope, N Gimenez, K Rodriguez-Capote, J Wils, ...
Critical reviews in clinical laboratory sciences 54 (7-8), 471-494, 2017
A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods
M Oremus, R McKelvie, A Don-Wauchope, PL Santaguida, U Ali, C Balion, ...
Heart failure reviews 19 (4), 413-419, 2014
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review
RA Booth, SA Hill, A Don-Wauchope, PL Santaguida, M Oremus, ...
Heart failure reviews 19 (4), 439-451, 2014
Evidence based application of BNP/NT-proBNP testing in heart failure
AC Don-Wauchope, RS McKelvie
Clinical biochemistry 48 (4-5), 236-246, 2015
Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity
D Armstrong, AC Don-Wauchope, EF Verdu
Canadian Journal of Gastroenterology 25 (4), 193-197, 2011
B-type natriuretic peptide-guided therapy: a systematic review
C Balion, R McKelvie, AC Don-Wauchope, PL Santaguida, M Oremus, ...
Heart failure reviews 19 (4), 553-564, 2014
Laboratory challenges in primary aldosteronism screening and diagnosis
M Rehan, JE Raizman, E Cavalier, AC Don-Wauchope, DT Holmes
Clinical biochemistry 48 (6), 377-387, 2015
Unreliability of triglyceride measurement to predict turbidity induced interference
PJ Twomey, AC Don-Wauchope, D McCullough
Journal of clinical pathology 56 (11), 861-862, 2003
Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms
PA Kavsak, AC Don-Wauchope, SA Hill, A Worster
Clinical chemistry 62 (6), 887-889, 2016
Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values?
AC Don-Wauchope, VT Chetty
Clinical biochemistry 42 (9), 766-770, 2009
The system can't perform the operation now. Try again later.
Articles 1–20